14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
OABIW vs ICUCW: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, OABIW (OABIW) is the stronger overall head-to-head candidate over SeaStar Medical Holding Corporation Warrant (ICUCW) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). OABIW carries a Unified Composite Score of 49.4/100 (HOLD) at $0.41 (N/M Forward P/E, N/A operating margin), whereas ICUCW carries 47.0/100 (HOLD) at $0.01 (N/M Forward P/E, N/A operating margin).
Technical & Structure Timing Caution: OABIW trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile ICUCW is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OABIW vs ICUCW. Trailing 12-month operating profitability (OABIW N/A vs ICUCW N/A) and valuation multiples (OABIW N/M vs ICUCW N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Surgical & Medical Instruments & Apparatus Operator
Competes within the Surgical & Medical Instruments & Apparatus value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ OABIW vs ICUCW Key Questions & Quantitative Answers
As of Nov 20, 2026, OABIW (OABIW) is the stronger overall head-to-head candidate over SeaStar Medical Holding Corporation Warrant (ICUCW) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). OABIW carries a Unified Composite Score of 49.4/100 (HOLD) at $0.41 (N/M Forward P/E, N/A operating margin), whereas ICUCW carries 47.0/100 (HOLD) at $0.01 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: OABIW trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile ICUCW is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
OABIW and ICUCW split Growth & Scale metrics: OABIW posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ICUCW at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, OABIW generates N/A in USD-normalized revenue versus N/A for ICUCW. In operating R&D and SG&A reinvestment, OABIW deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ICUCW.
OABIW and ICUCW trade at balanced relative valuation multiples. OABIW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ICUCW trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OABIW (N/A ROE) versus ICUCW (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, OABIW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-4.10β · 376% Vol realized risk). By comparison, ICUCW carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.08β · 366% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.